Tech Company Financing Transactions
Freedom Meditech Funding Round
Freedom Meditech, based in San Diego, raised $7 million from private investors.
Transaction Overview
Company Name
Announced On
8/6/2013
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series B
Investors
Proceeds Purpose
Funds will support the U.S. commercial launch of the ClearPath DS-120 Lens Fluorescence Biomicroscope which was cleared by the U.S. Food and Drug Administration (FDA) earlier this year. The capital raised will also support the clinical development of the I-SugarX, a non-invasive personal glucose meter for people with diabetes that is operated by holding a small handheld device in front of the eye.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5090 Shoreham Pl. 109
San Diego, CA 92122
USA
San Diego, CA 92122
USA
Phone
Website
Email Address
Overview
Freedom Meditech provides alternatives to existing diagnostic tools for the detection, monitoring and management of chronic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Gerace
Chief Operating Officer
Keith Ignotz
Chief Scientific Officer
John Burd
VP - R & D
Paul Williams
Browse more venture capital transactions:
Prev: 8/6/2013: Maxwell Health venture capital transaction
Next: 8/6/2013: Vaxart venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs